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Abstract
Background: Brucellosis is a debilitating zoonotic disease affecting humans and animals. A comprehensive,
evidence-based assessment of literature and officially available data on animal and human brucellosis for Kenya are
missing. The aim of the current review is to provide frequency estimates of brucellosis in humans, animals and risk
factors for human infection, and help to understand the current situation in Kenya.
Methods: A total of accessible 36 national and international publications on brucellosis from 1916 to 2016 were
reviewed to estimate the frequency of brucellosis in humans and animals, and strength of associations between
potential risk factors and seropositivity in humans in Kenya.
Results: The conducted studies revealed only few and fragmented evidence of the disease spatial and temporal
distribution in an epidemiological context. Bacteriological evidence revealed the presence of Brucella (B.) abortus and B.
melitensis in cattle and human patients, whilst B. suis was isolated from wild rodents only. Similar evidence for Brucella
spp infection in small ruminants and other animal species is unavailable. The early and most recent serological studies
revealed that animal brucellosis is widespread in all animal production systems. The animal infection pressure in these
systems has remained strong due to mixing of large numbers of animals from different geographical regions,
movement of livestock in search of pasture, communal sharing of grazing land, and the concentration of animals
around water points. Human cases are more likely seen in groups occupationally or domestically exposed to livestock
or practicing risky social-cultural activities such as consumption of raw blood and dairy products, and slaughtering of
animals within the homesteads. Many brucellosis patients are misdiagnosed and probably mistreated due to lack of
reliable laboratory diagnostic support resulting to adverse health outcomes of the patients and routine disease
underreporting. We found no studies of disease incidence estimates or disease control efforts.
Conclusion: The risk for re-emergence and transmission of brucellosis is evident as a result of the co-existence of
animal husbandry activities and social-cultural activities that promote brucellosis transmission. Well-designed
countrywide, evidence-based, and multidisciplinary studies of brucellosis at the human/livestock/wildlife interface are
needed. These could help to generate reliable frequency and potential impact estimates, to identify Brucella reservoirs,
and to propose control strategies of proven efficacy.
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Background
Brucellosis is one of the most common zoonoses world-
wide. The disease has been eliminated substantially in
several developed countries including Australia, Japan, New
Zealand, Canada, and some European countries, but it re-
mains a major public health problem in Mediterranean re-
gion, Middle East, Africa, Latin America, and parts of Asia
[1]. The disease affects are wide range of domestic and wild
animals causing abortions, reduced milk yield, and infertil-
ity resulting in tremendous economic losses in livestock
production [2]. In humans, Brucella cause systemic infec-
tions with an acute, subacute, or chronic relapsing course.
Clinical presentation of human brucellosis is nonspecific
and highly variable. Patients commonly have a wide range
of symptoms including undulant fever, headache, chills,
myalgia, and arthralgia. The disease is also associated with
abortion, orchitis, acute renal failure, endocarditis, splenic
abscess, spondylitis, arthritis, and encephalitis [3–5]. Up to
date, the genus Brucella includes 12 accepted nomo-species
but only B. melitensis, B. abortus, B. suis, and in rare cases
B. canis are considered to be human pathogens. The
zoonotic potential of the remaining species has not yet been
confirmed [6, 7]. Animals and their products are the main
source of human brucellosis. Transmission occurs via the
consumption of unpasteurized dairy products or direct
contact with infected animals through skin abrasions or
mucous membranes [8]. Individuals with occupational live-
stock contact such as farmers, veterinarians, abattoir
workers, and livestock keepers are at high risk of infection.
The families of these groups are also at high risk as domes-
tic exposure may be unavoidable when animals are kept in
close proximity to living areas [1, 8, 9].
Diagnosis of brucellosis in sub-Saharan Africa is often
challenging to clinicians due to the wide spectrum of clin-
ical manifestations and lack of reliable diagnostic tests.
This frequently results in misdiagnosis as malaria or other
febrile diseases. Thus brucellosis remains severely under-
reported [10–12]. Approximately, about 500,000 new
cases are estimated to occur every year globally [1]. Des-
pite this and the high burden of the disease in many low-
income countries, the disease does not attract the appro-
priate attention of health systems. Thus brucellosis is
presently classified as one of the top neglected zoonosis
by World Health Organization (WHO) [13].
In sub-Saharan Africa, brucellosis is endemic in coun-
tries with extensive pastoral production systems where
surveillance and control are rarely implemented. It is
often ignored in humans potentially leading to considerable
suffering of the patients [12]. In Kenya, livestock produc-
tion is a rapidly growing economic activity for communities
that live in the high rainfall areas for intensive dairy produc-
tion. Agro-based pastoralism, extensive pastoralism, and
commercial beef production are common in the arid and
semi-arid lands (ASAL) [14]. However, the high incidence
of tropical vector borne diseases and re-emerging infectious
diseases in animals hinders animal production and inter-
national livestock market due to trade sanctions [15].
Though the first case of brucellosis was described in
Kenya in 1916, scanty data are available on the disease bur-
den estimates and a comprehensive, evidence based assess-
ment of the literature is missing. A better understanding of
the epidemiology of brucellosis (prevalence estimates,
affected host species, risk factors, potential reservoirs, and
prevalent Brucella species) would be important for recom-
mending a prevention and control strategy.
In this systematic review, we evaluate and summarize
relevant articles reporting on the presence, frequency, and
control of brucellosis in humans and animals in Kenya.
We also present findings on the associations between po-
tential risk factors and seropositivity in humans to verify
the current situation of brucellosis in the country.
Methods
Systematic review protocol
A systematic review was conducted using a predefined
protocol based on PRISMA [16] guidelines including: (i)
literature search to identify potential articles of rele-
vance, (ii) assessing the relevance of the articles, (iii)
quality assessment and (iv) data extraction. Figure 1
summarizes the number of articles that fulfilled the ne-
cessary criteria at each step.
Literature search and data collection
Search in the database search engines (PubMed, Google
scholar, African Journals Online, Science Direct, Cabdir-
ect) was undertaken using different search terms and
Boolean Operators including,
(i) Brucellosis OR Brucella OR Brucel* OR Zoonoses OR
Zoonotic diseases OR zoonos*
AND
(ii) Kenya OR Africa.
AND
(iii)Humans OR Wildlife OR Domestic AND Ruminant
OR (cattle OR bovine) OR (Camel OR Dromedary)
OR (Sheep OR ovine) OR (Goat OR Caprine).
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AND
(iv)Prevalence OR Incidence OR prevention AND
control OR Risk Factors.
We also applied wildcard symbol (*) in some of the
searches. During the searches, the combinations were
either relaxed or broadened to capture more articles
or were restricted to refine the number of resulting
articles. Other related articles emerging during the
searches were also considered as sources of additional
information. Bibliographies of selected papers were
also reviewed.
Similar search terms were used for obtaining additional
information from the published grey literature materials.
Publications not available on-line were searched through
personal visits to the Kenyan university libraries and gov-
ernment departments. No time limits were set. The studies
or reports unrelated to the predetermined criteria were
then excluded. These included those describing studies
conducted outside Kenya, immunology experiments, incor-
rect pathogens, duplicate data published elsewhere, reviews
or lay media content and textbooks/manuals.
We used a broad inclusion criterion to allow us to
identify the presence of the disease, limitations of the
Fig. 1 Search strategy and paper selection flowchart showing the numbers of articles at each stage of the systematic review
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diagnostic tests used, potential risk factors, Brucella host
ranges and reservoirs, transmission dynamics, disease
diagnostics, control programmes, and the gaps from
which lessons can be drawn.
Data screening
The abstracts of the retrieved articles were screened by
the primary author based on the following criteria:
 The article reported original data on brucellosis in
Kenya,
 The article provided information on occurrence
([sero-prevalence] and/or incidence) or outbreak
report of Brucella spp. in animals and/or humans,
 The article described case reports/series of Brucella
spp. infection in animals and/or humans,
 The article reported on control programmes,
 The publication investigated the associations of
potential predisposing risk factors and Brucella spp.
infection or seropositivity in humans.
For articles whose relevance could not be determined
by reading the abstract alone, full texts were retrieved
and the quality assessment of the article conducted.
Quality assessment and data extraction
A full text analysis for each publication was done by two
independent reviewers using a pre-designed data extrac-
tion form and the quality assessment for eligibility was
conducted for each article independently.
Each of the reviewers assessed the ability of the article
to fulfill the following criteria:
(i) A description of the study design or the sampling
strategy and approach applied,
(ii) For prevalence studies, case studies or case series, at
least one classical diagnostic test was applied,
(iii)The study population and sample size was described
for epidemiological studies,
(iv)For epidemiological studies, the study region and
period were specified,
(v)For studies investigating the risk factor for Brucella
infection, estimates of the strength of association are
provided,
(vi)Possibility of the reviewer to obtain information on
animal production and management system.
Those that fulfilled the quality assessment were con-
sidered to be of sufficient quality to provide evidence of
the occurrence of brucellosis in different host popula-
tions in Kenya or possible predisposing risk factors. Pub-
lications describing brucellosis investigations were
included even if statistical analyses applied were not
sound to promote data acquisition.
Data was then extracted on:
 Animal species involved,
 Brucella species or their biovars identified,
 Relative risk and odds ratio estimates of the strength
of association between Brucella seropositivity in
humans and potential risk factors,
 Disease prevention or control methods used,
 Type of study,
 Study outcome and reviewer comments,
 Location of study,
 Study population,
 Study period,
 Sampling approach (probability or nonprobability
sampling),
 Diagnostic test used,
 Sampling strategy,
 Bias and/or gaps in sampling method described.
 The sampling strategy for animals was categorized
into herd, flock, individual, abattoir, meat market,
and milk markets. For the farm studies, the livestock
production system was identified and where
multiple surveys were reported in a single study,
each survey was listed separately.
Results
Data acquisition
The initial database searches revealed 427 research arti-
cles and after removing duplicates and those that did
not meet the eligibility criterion, 36 articles remained for
data extraction and qualitative analysis. These included
thirteen articles reporting the occurrence of brucellosis
or providing estimates of brucellosis frequency in
humans [17–29], three studies on livestock and humans
[30–32], and two studies reported on potential risk fac-
tors for human brucellosis seropositivity [33, 34]. Fifteen
studies reported brucellosis in livestock [35–49], two in
wildlife [50, 51], and one article in mixed livestock and
wildlife herds [52] Fig. 1.
The range of the years of publication was 1931–2016
with a median of 2008 and 1990 for human and animal
studies, respectively. The studies were heterogeneous in
terms of study design within human groups or animal
subpopulations under investigations and sample size.
The majority of the studies did not report probability
sampling and others did not specify the sampling
strategy used at all. Thus data were only extracted, sum-
marized, and organized in a qualitative manner.
To summarize and compare data of Brucella-specific
antibody based studies, one test result value (that met the
recommended titer cut-off of the respective test method
used) per study is reported in the following preferential
order: Rose Bengal Plate test (RBT), Enzyme-Linked Im-
munosorbent Assay (ELISA), Complement Fixation Test
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(CFT), Serum Agglutination Test (SAT). The rationale for
this preferential selection is based on the proposed
sensitivity/specificity superiority generated through meta-
analytical logistic regression model algorithms that allows
adjustment for confounding factors for specificity and sen-
sitivity of the classical Brucella diagnostic tests [53]. For
studies where milk was screened with Milk Ring Test
(MRT), these values are reported.
Among livestock studies reporting disease frequency
estimates, we present only prevalence ranges after taking
into consideration the heterogeneous nature of the re-
trieved studies.
Most studies screened blood or milk with multiple
serological tests and reported disease frequencies based
on the results of each individual test. One and five stud-
ies, respectively, reported brucellosis based on molecular
and bacteriological evidences. A summary of the studies
which used classical serological tests, bacterial isolation
and molecular methods is shown in Fig. 2.
Evolution and spatial distribution of publications
Brucellosis was first reported in Kenya in 1916 but the
first laboratory confirmed case was reported in 1931.
The period from 1970 to 2010 was characterized by a
progressive increase in the number of animal and human
studies. Between the years 2010 and 2015, a sharp in-
crease in the number of human studies occurs while the
number of animal studies decreased. All studies were re-
gional except one that conducted a national seropreva-
lence survey of human brucellosis in 2007. The
distribution of studies by animal species and humans in
each of the Kenyan provinces is shown in Fig. 3a while
the number of studies according to year of publication
and host investigated is shown in Fig. 3b.
Human brucellosis
The frequency of brucellosis in humans was investigated by
16 studies including 10 hospital-based studies, 2 population
based studies, 3 studies among high risk occupational
groups, and 1 outbreak investigation. Of these, only one
study [24] described a nationwide population-based surveil-
lance for human brucellosis. The study found an estimated
national seroprevalence of 3.0 %. No case was found in
Nairobi and Nyanza provinces, while low levels of exposure
were found in other provinces. Relatively higher seropreva-
lence was found in the Northeastern province. Of the other
studies, evidence of human brucellosis was reported in six
of the eight Kenyan provinces. Three early case series/re-
ports described brucellosis in patients treated and followed
up at Nairobi and Machakos hospitals. The disease was
found in Africans, Asians, and Europeans [19, 25, 29]. A
study by Paul et al. (1995) reported brucellosis in HIV and
non-HIV infected patients of a study cohort in Nairobi
[27]. Ari et al. (2011) reported a brucellosis associated
outbreak of acute febrile illness among pastoralists in a
remote part in Northeastern Kenya [17]. Other sero-
epidemiological studies revealed high prevalence of brucel-
losis in humans from five counties: Kanjiado (Rift valley
province), Narok (Rift valley province), Marsabit (Eastern
province), Turkana (Rift valley province), Machakos
(Eastern province), and Garissa (Northeastern province).
Comparatively, low seroprevalences were found in Busia
(Western province), Nairobi (Nairobi province), Kiambu
(Central province), and Naivasha (Rift valley province).
Fig. 2 The number of studies in which specific diagnostic tests were used. The data table corresponds to the total number of studies that have
employed each test for each species. The overall number of studies is greater than the total number of papers reviewed because many studies
applied more than one test method. ELISA: Enzyme-Linked Immunosorbent Assay, RBT: Rose Bengal Plate Test, SAT: Serum Agglutination Test,
CFT: Complement Fixation Test, IFA: Immuno Fluorescence Antibody Assay, MRT: Milk Ring Test, BMAT: Brucella Micro-Agglutination Test
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The animal-human linked study by Osoro et al. (2015)
found evidence of strong association between human
and animal seropositivity [32]. Table 1 shows the sum-
mary of brucellosis studies on humans and Fig. 3a, the
number of studies conducted per province.
RBT was the primary diagnostic test applied in 11
(68.8 %) studies. Of these, seven studies had at least a
complementary serological test including: CFT, SAT,
ELISA, IFA or Coombs test. One study demonstrated
evidence of Brucella infection in febrile patients using
PCR, while three case report or series provided bacterio-
logical evidence of Brucella infection in human patients
Table 1.
Animal brucellosis
A total of 21 studies investigated the frequency of bru-
cellosis in different animal species from various produc-
tion systems (Table 2). In camels, the seroprevalence
ranged from 4.6 to 38 % from pastoral managed camel
herds in northern Kenya, and 8.0 % in a single exten-
sively managed commercial ranch in the coast region
[32, 39, 46, 48, 52].
In cattle, the seroprevalence from pastoral and agro-
pastoral managed herds ranged from 9.9 to 15 % in the
studied regions of Northeastern province [38], Kanjiado
(south Rift valley) [43], Turkana (north Rift valley) [30],
and Marsabit and Samburu (upper Eastern) [32, 37, 45].
The seroprevalence was relatively higher (10.7 %–14.9 %)
in Samburu, while that from Kilifi increased from 4.1 to
9.0 % in two studies conducted in the same regions about
20 years apart [37, 45].
Studies of cattle from small holder production system
regions found seroprevalences below 2.5 % in Kiambu
[32, 37, 45]. High seroprevalence of brucellosis and a
probable brucellosis associated outbreak were revealed
in cattle from extensive beef production commercial
ranches in the Coast and upper Eastern regions, respect-
ively. The cattle shared the grazing pastures with domes-
ticated wild animals [49, 52].
In goats, the high seropositivity was found from
pastoral managed herds in north Rift Valley and the
upper Eastern regions [30, 32]. Low seroprevalence of
brucellosis was found in goats and sheep from small
holder farms in Kiambu (Central). No case was de-
tected in a single seroprevalence study conducted in
Busia (Western) Kenya [35]. Similarly, low seropreva-
lences were reported in small ruminants from agro-
based pastoralists’ herds in Kanjiado while none was
found in an extensive mixed herd ranch in the coastal
region [30, 32].
Serological evidence of Brucella infection was found in
0.2 % pigs in an abattoir study in the Central province
[47], whilst an early study found high seroprevalence in
wildebeest and African buffalo from Maasai Mara (south
Fig. 3 a Map of Kenya showing the distribution and number of brucellosis studies conducted in the last 100 years according to host species per
province. Kenyan Provinces: CEN (Central), CST (Coast), (EAST) Eastern, NBI (Nairobi), NEP (North Eastern), WES (Western), NYZ (Nyanza), (RFT) Rift
Valley. Host species: H: human, SR: small ruminant, Ct: cattle, Cm: camel, P: pig, Wld: wildlife. b The number of studies conducted per decade in
Kenya according to hosts, included in the systematic review
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Rift Valley) [51]. The animals shared grazing and water-
ing areas with cattle of Maasai communities who are
predominantly pastoralists.
In milk based studies utilizing ELISA and MRT assays,
low brucellosis detection was reported in raw milk samples
sold in small units in urban markets in Nairobi and Eldoret
(central Rift Valley). In contrast, more positives were re-
ported from milk originating from the extensive production
units in Nakuru (south Rift Valley) [36, 40, 42]. Nyaga,
(2010) found high seroprevalence of Brucella antibodies in
milk obtained from informal market agents in Narok and
Kiambu in Central province [31]. In Nairobi, low bovine
brucellosis prevalence was reported in milk samples from
non-dairy farming households and from dairy farming
households [40].
RBT was used in 10 of 19 studies and was either com-
plemented with ELISA or SAT and CFT in one and seven
studies, respectively. Consumption of locally fermented
milk products prepared from raw milk was commonly
reported among rural and urban households across
Kenyan regions, whereas consumption of raw milk was
only reported among rural households [36, 40, 42].
In studies of pathogen shedding in bovine milk and
other animal secretions/birth products, Brucella was iso-
lated in two studies. Heisch et al. (1963) isolated B. suis
from wild rodents caught at the Kenyan coast [50].







Diseases frequencya Risk factor
























Outbreak patients Garissa RBT/BMAT ELISA,CFT 5 of 12 outbreak cases No [17]
Hospital patients Narok RBT NA 21.2 (13.8–35.9) No [23]
Hospital patients Machakos RBT SAT 39 patients case series report No [25]
Hospital patients Machakos RBT CFT,SAT 10.4b No [26]
Hospital patients Garissa RBT PCR 31.8b Yes [21]
High risk pastoralist population Isiolo QS NA QS Yes [33]
Hospital patients Nairobi RBT ELISA 5 (1.4–9.4) No [22]
Hospital patients Nairobi ELISA Isolation 2 BM isolates and 21 seropositive
from study cohort
No [27]
High risk pastoralist population Turkana RBT ELISA 17 (13.1–22.4) Yes [30]
Hospital patients NS RBT Isolation 70 isolates (64BM,6BA) from case reports No [29]
Hospital patients NS Isolation NA 1 BA isolate




RBT/SAT IFA 3.2 (1.1–4.5)
14.4 (8.0–18.9)
No [31]
High risk occupational groups Nairobi
Naivasha
SAT NA 2 (0.5–4.5)
7 (4.1–14.6)
No [20]
High risk pastoralist population Marsabit QS NA QS Yes [34]
High risk occupational groups Busia RBT NA 0.1 (0.007–0.8) No [18]
Hospital patients Busia RBT BPAT, Coombs, SAT 0.6 (0.04–0.9) NO [28]
aSeroprevalence estimates (bold) with the corresponding 95 % Confidence Intervals or outcome from outbreak investigation/case reports/case series
b95 % Confidence Interval not provided, NA not available, Ref reference, BA B. abortus, BM B. melitensis, ELISA enzyme-linked immunosorbent assay, RBT rose bengal plate
test, SAT serum agglutination test, CFT complement fixation test, IFA immuno fluorescence antibody assay, BMAT Brucella micro-agglutination test, NS not specified, QS
qualitative studies without laboratory investigations (Cases defined as individuals diagnosed and treated for brucellosis in the past one year)
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Table 2 Summary of brucellosis studies in animals in Kenya identified as relevant to be included in this systematic review
Population production system Test (No. of studies)a % Range of seroprevalenceb Reference







S(1), C(1) 10.3–38.0 9.9–16.9 11.9 13–16.1 18–30 [30, 32, 37–39, 43
45, 46, 48, 51]
Agro-pastoralist - E(1), R(1),
S(1)
E(1), R(1) E(2), R(1) E(1), M(1) - 3.3-10.0 0–3.4 3.6–5.0 [32, 36]
Small holder - E(2), S(1) E(1) E(1), R(1) M(3)
E(2)












R(1), S(1), C(1) 8 17& 7/10
cases
0 0 - - 0-14 [49, 52]
Not specified I(1) M(1)
E(1)
I(1) 0–10 [41, 50]
aRange of diagnostic tests and respective number of studies for each test on which individual prevalence values have been based
bProportions of animals positive for brucellosis based on the prioritized tests selection criteria














Meundo et al. (2012) isolated five B. melitensis biovar 1
strains from bovine milk samples and ten B. abortus bio-
var 3 strains from aborted fetus materials and vaginal
discharge fluids from cattle of the Central and Eastern
provinces [41]. The cattle were from five mixed herds in
which reproductive problems were reported. Figure 3a
shows the summary of the number of studies by animal
species in each of the Kenyan provinces and Table 2, the
numbers and prevalence ranges according to livestock
production system.
Risk factors associated with human brucellosis
Our search identified six studies that measured the
strength of association between potential risk factors
and human brucellosis. One of them was a case
control study, while the others used logistic regression
models to investigate the associations of putative risk
factors and Brucella seropositivity. Details of these
studies and the corresponding odds ratios (OR) are
summarized in Table 3. Generally, contact with live-
stock and their products were significant risk factors
for Brucella infection. Consumption of raw milk was
significantly associated with brucellosis in six out of
seven counties in which studies were conducted. In
these counties, the communities are mainly agro-
pastoralists or predominantly nomadic pastoralists
[21, 30, 32–34]. In studies conducted in Marsabit [32]
and Isiolo [33], positive associations were found
between seropositivity and contact with aborted mate-
rials and helping animals during birth. Further studies
in Marsabit [34] and Turkana [30] revealed that con-
tact with cattle and consumption of raw animal blood
increased the risk of seropositive status. Male sex and
advanced age were significant risk factors for sero-
positivity, while having at least basic education was
protective [24, 32] (Table 3). An old case report study
by Jewel, (1931) found that a patient infected with B.
abortus had previously attended an aborting cow. The
infection was subsequently linked to the cow using
classical serological tests [19]. In a linked study across
three livestock production systems, human brucellosis
serostatus was positively correlated with the number
of seropositive animals. Households that practiced the
pastoral production systems and nomadic movements
were at highest risk for brucellosis seropositivity.
Handling of animal hides in a small holder system
was a major risk factor for seropositivity [32].
Brucellosis control
We found three studies that described vaccination ex-
periments in goats, sheep, and cattle in government
farms but did not qualify for data extraction during
quality assessment. At the time of this review, no reports
of disease incidence estimates and awareness or control
programmes in Kenya were found.
Discussion
Our work aimed to systematically review the trend of
the data on brucellosis presence and frequency estimates
in humans and animals, and associations between poten-
tial risk factors and human seropositivity in Kenya. The
serological data reviewed in this study reveal evidence of
widespread Brucella exposure in humans and multiple
animal species in multiple regions throughout Kenya.
However, despite evidence of the pervasiveness of this
pathogen, we found only 36 studies/reports that were
deemed of sufficient quality to provide reliable data use-
ful to inform on disease burden estimates, or proposal of
targeted disease prevention strategies based on specific
risk factors. Though brucellosis was first reported in
Kenya in 1916 [29], the quantity and quality of epidemi-
ologic research for this pathogen is limited. No descrip-
tions of disease incidence estimates appear in published
literature.
In addition, our review revealed that majority of stud-
ies has limited validity that hinders the adjustment of
observed apparent seroprevalences to obtain true sero-
prevalence. Most articles reported seroprevalence esti-
mates from studies with unclear study designs, or
sampling approaches that were likely to generate biased
estimates due to non-probabilistic sampling and small
sample sizes, while some studies compared the sero-
prevalence in purposively selected populations. More-
over, the sampling techniques used in majority of the
studies did not account for the clustering of animals
within the herd or flock, which may have resulted in in-
accurate estimates [54]. Another critical issue with some
studies is the differences in performance of the diagnos-
tic tests used, and the lack of standardization of diagnos-
tic tests (i.e., origin of Brucella antigens, control sera
and the cut-off criteria). The lack of consideration of
prior vaccination against brucellosis in some animal
herds would also have led to misleading estimates of
average prevalence.
Only one investigation reported nationwide brucellosis
seroprevalence in humans and none was found for ani-
mals. Our search identified one study that used random
sampling procedures in linked human and animal live-
stock populations [32].
To understand brucellosis epidemiology, it is essential
to isolate the Brucella species and characterize the
prevalent biovars because the available serological tests
have the limitations of specificity and sensitivity.
In humans, only five studies provided bacteriological
data on brucellosis. Three case-series studies described
isolation of seven B. abortus and 66 B. melitensis isolates
in patients treated and followed up in Nairobi and
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Machakos hospitals [19, 27, 29]. Except in one study,
much of these data were collected more than 50 years
ago and the methodologies used for pathogen cultivation
and species identification are atypical or completely
missing.
In animals, one study succeeded to isolate B. suis from
wild rodents [50], but this early study reported scanty
epidemiological data to allow drawing any realistic epi-
demiological conclusions. Recently, B. melitensis biovar
1 and B. abortus biovar 3 strains have been isolated from
cattle in the Central and Eastern provinces [41]. Further
genotyping revealed close molecular homology of the B.
melitensis biovar 1 with a strain originating from Israel,
and the B. abortus biovar 3 was closely related to a
strain from neighboring Uganda suggesting a wide geo-
graphic distribution of these genotypes. Both B. abortus
and B. melitensis were isolated from cattle, and none of
these was found in small ruminants kept in the same
Table 3 Summary of the studies investigating the potential risk factors showing the variables found to be associated with human
brucellosis seropositivity
County Study population characteristics Variable Risk factors (aOR, 95 % CI)a Ref
Marsabit Pastoral Individual Age by decade
Male sex
Use of milk from own animals
Assist in animal delivery
Exposure to sheep
Exposure to goats

















Kiambu Small holder Individual Age by decade





Household Male household head





Kanjiado Agro-pastoral Individual Age by decade
Use of milk from own animals
Regular ingestion of raw milk
Exposure to sheep








Household Pastoral production system
Nomadic movements
Male household head
Use of calving pens






National Diverse Individual No education
Male





Garissa Pastoral Individual Consumption of raw milk




Isiolo Pastoral Household Drinking raw milk
Contact with aborted materials or





Turkana Pastoral and small holder Individual Pastoral production system
Drinking raw blood
Animal slaughter
Communal grazing (exposure to goats)
Communal grazing (exposure to cattle)
1.8 (p = 0.007)
1.4 (p = 0.025)
1.9 (p < 0.001)
1.6 (p = 0.003)
2.8 (p < 0.001)
[30]b
Marsabit Pastoral Household Women
Drinking of raw blood
Consumption of raw milk
Household milk harvesting
1.62 (p < 0.001)
1.64 (p < 0.001)
1.64 (p = 0.001)
3.87 (p < 0.001)
[34]b
aadjusted Odds Ratios at 95 % Confidence Interval with p < 0.05
b95 % CI values unavailable in the study
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herds. B. melitensis preferentially infects sheep and goats
but may infect and persist in cattle as well [55]. Further
studies are warranted to investigate the significance of
cattle in brucellosis maintenance and transmission in the
mixed breeding systems of Kenya.
Brucellosis in humans
The history of brucellosis in Kenya dates back to 1916
when the first case was reported. Since then, conducted
studies show high seroprevalence levels (14.4–46.5 %) in
local pastoralists and agro-pastoralists (7.0–15.3 %) in the
different Kenyan regions. Conversely, low levels were re-
ported in individuals from small holder regions (0.1–2.4 %).
One recent serological study found a strong statistical
association between human and animal seropositivity [32].
These findings and those from previous studies may sug-
gest that human brucellosis is likely linked to infection of
livestock species, but research gaps remain i.e., in the ab-
sence of bacteriological evidence or molecular based tests,
this argument has to be interpreted with caution because
serological positive results can be caused by previous
exposure to infection or cross-reactivity. Additionally, co-
occurrence of anti-Brucella antibodies in animals and
humans may also suggest a common other source as op-
posed to source attribution. This knowledge gap highlights
the need for bacteriological and molecular typing data to
demonstrate pathogen reservoirs, transmission dynamics,
and how Brucella pathogen may be embedded in livestock
management practices within ecologically heterogeneous
regions of Kenya.
None of the past population-based seroprevalence
studies aimed to isolate the organism. A single PCR
based study screened patients’ sera for Brucella DNA
using genus specific primers [21]. Therefore, it is cur-
rently not known to what extent human brucellosis in
Kenya is caused by B. abortus or B. melitensis or both.
Human brucellosis commonly presents as febrile ill-
ness. This makes accurate diagnosis and management in
areas without access to reliable laboratory diagnosis a
great challenge. The previous hospital based studies
underscored the importance of laboratory supported
clinical diagnosis. The studies found that patients with
flu-like syndrome who were not tested for brucellosis
were frequently treated for other common tropical infec-
tions [23, 26, 28, 56]. Other authors highlighted the poor
performance of commonly available Brucella antigens
for rapid agglutination test when performed without at
least semi-quantitative estimation of titers or a comple-
mentary test [20, 21, 28]. In most health care facilities,
brucellosis diagnosis is not routinely done and testing is
considered only after the patient had initially been
treated for malaria and not responded [12]. Furthermore,
recent findings show that clinicians in Kenya continue
to empirically treat febrile patients for malaria even after
a negative rapid malaria test [57, 58]. Our search did not
identify hospital based studies in Kenya’s malaria en-
demic zones (Nyanza and Coast provinces) [59], while
one was found for the Western province [28]. It is not
clear if this is likely caused by low incidence of brucel-
losis or if infections are unrecognized because of in-
accurate diagnosis.
Brucellosis in animals
Majority of brucellosis studies in animals were mainly
serological targeting bovines and camels, and only rarely
in small ruminants. Studies done before the year 2000
used RBT as the primary assay or in combination with
SAT or CFT. Whereas RBT exhibits high sensitivity, the
assay has poor specificity due to cross reactivity with other
pathogens or failure to differentiate natural infections
from the effects of vaccination [53, 60, 61]. In addition,
RBT standardization and antigen origin was adequately
described in 3 of 10 studies and two investigations used
locally prepared antigens. Generally, ELISAs are consid-
ered to be more specific and sensitive. However, our
review found that the past studies used commercial ELISA
kits without prior validation of the kits under local condi-
tions. Though sparse vaccination has been conducted in
Kenyan animals before [12], only one author mentioned
whether the sampled animals were vaccinated or not.
Therefore, the serological data reported in these studies
have to be interpreted with caution.
Kenya’s livestock population is presently estimated at
18 million beef cattle, 28 million goats, 18 million sheep,
3 million camels, 0.52 million donkeys, and 0.3 million
pigs. Of these, approximately 60 % are reared in pastor-
alist or agro-pastoralist production and management
systems [62]. Indeed, the majority of the studies were
conducted in regions in which the two systems are the
main economic activities. Despite livestock brucellosis
being detected in animals from all livestock production
systems, the seroprevalence were seemingly higher in
pastoral grazing systems when compared to smallholder
mixed crop or dairy farming systems. High seropreva-
lence i.e., 9.9–16.9 % for cattle, 11.9 % for sheep, and
13.0–16.1 % for goats were found in pastoralist managed
herds [30, 32, 37, 38, 43, 45]. In contrast, seroprevalences
of 0.8–2.4 % in cattle, 2.4 % in sheep, and 0–1.3 % in goats
were reported in herds managed from small holder farms
[32, 35, 45]. The variation may be caused by mixing of
large numbers of animals, movement of livestock in
search of pasture, sharing of grazing areas with wildlife,
and concentration of animals around water points. Sero-
prevalence tended to be lower in agro-pastoralists man-
aged herds than in pastoralist managed herds but
prevalence varied (3.3–10 %) from one region to the other
[26, 32, 37, 38]. This is possibly reflecting the differences
in herd size and grazing patterns that highly depend on
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farm size [63]. Interestingly, this situation seems not to
have changed over the years. For instance, three studies
with intermission of 20 years done in three distinct agro-
ecological zones found consistent or higher rates in
extensive pastoral regions [32, 37, 45]. These findings show
brucellosis in ruminant animals in most pastoral and agro-
pastoral areas of the country may pose a sustained high risk
for human infection.
There are only few serological studies in camels available.
Additionally, these studies were largely confined to
northern Kenya. The recent census report has shown that
camel population in Kenya increased between 0.8 million
and 3 million from 1999 to 2009 [64] causing a significant
shift from subsistence to market production of camel milk
for those living in the ASAL of Kenya [65]. However, this
increase did not get a matched attention from public and
veterinary health necessary to effectively control infectious
diseases in an emerging population. Indeed, our search
found only a single study on camel brucellosis since 1990.
Early studies reported high seroprevalences of 10.3–38.0 %
suggesting that brucellosis may be high but more extensive
epidemiological research is crucial to help understand the
pathogen’s ecology or prevalence in camels across Kenya.
Our search did not identify any reports of brucellosis
in dogs, horses, and donkeys. Studies in several African
countries, however, have reported the infection in these
animals when kept in close contact with infected live-
stock [66–68]. This situation is also common in Kenya
and the role of these animals in maintenance and trans-
mission of brucellosis should not be underestimated. We
found one small scale abattoir study reporting low
prevalence (0.2 %) for pigs in central Kenya in 1976.
Therefore, the situation of brucellosis in pigs still re-
mains unknown and needs further investigation.
Wildlife surveys revealed seroprevalence of 30, 18, 14,
and 5 % in African buffalo, blue wildebeest, eland, and
oryx, respectively, from extensive mixed ranching-and-
wildlife conservancy ranches [51, 52]. A brucellosis out-
break was also described in a commercial beef production
ranch in which an abortion storm was reported in cattle
and wildlife [49]. It was reported that the abortion rate in-
creased from 5 % in 2012 to 13 % in 2013 in cattle, while
six cases were detected among leopards, hyenas and lions
in the same period. In addition, B. suis was isolated from
rodents at the Kenyan coast [50]. Though the primary re-
sponsibility for diseases surveillance in domestic animals
and wildlife generally rests with the respective veterinary
and wildlife departments, there is need for epidemiological
investigations at the wildlife/livestock interface to guide
the development of effective control strategies.
Risk factors
The reports reviewed suggest that the risk factors for
human seropositivity are direct and indirect contact with
livestock and their products [19, 21, 31–34, 42, 69]. Due
to cultural habits and livestock husbandry practices that
are common amongst pastoralist communities, the stud-
ies identified risk factors linked to direct contact with
animals/products and consumption of contaminated raw
milk and blood. In contrast, low risk of infection was
found among individuals from intensive production sys-
tems and urban populations, and only direct contact
with infected animals or contaminated products (hides)
were found to be significantly associated with seroposi-
tivity. These differences can be attributed to high risk
practices among pastoralists’ communities that promote
brucellosis transmission such as (i) consumption of raw
milk and blood, (ii) nomadic movements, (iii) using
communal grazing lands and watering points for ani-
mals, and (iv) household slaughter of animals during
traditional and religious ceremonies [70, 71]. Gender
specific roles and responsibilities that are mainly associ-
ated with cultural practices predispose certain genders
to higher risk for human brucellosis. These practices
vary considerably among the multiple ethnic groups in
Kenya [24, 69, 71]. However, the available information is
scanty and warrant more detailed investigation.
Control of brucellosis
Prevention and control of brucellosis in humans largely
depends on successful control of the disease in livestock.
These goals have been achieved in some countries by
use of vaccination, test and slaughter policy and strict
control of animal movement [72, 73]. The Food and
Agriculture Organization (FAO) recommends different
control strategies for brucellosis in livestock depending
on baseline herd-seroprevalence estimates, prevailing so-
cioeconomic conditions, surveillance and monitoring
system available, and the control policy of the respective
countries [74].
In Kenya, vaccination against livestock brucellosis was
considered in early 1970’s and a series of vaccine trials
were done in government owned herds [75, 76]. How-
ever, animal vaccination against brucellosis is rarely con-
ducted and if done, it has been on an ad hoc basis rather
than as part of a coordinated national program [12]. We
found no report on human vaccination against brucel-
losis in Kenya.
In 2011, the Government of Kenya formed the Kenya
Zoonotic Diseases Unit (ZDU). This intergovernmental
unit aimed to establish collaborative programmes for ef-
fective prevention and control of zoonotic diseases in
Kenya. Then, brucellosis was included as one of the prior-
ity zoonotic diseases and gazetted as a notifiable disease in
Kenya under the animal diseases act the same year [77].
At the time of this review, we found no reports describing
coordinated national brucellosis control programmes. Re-
ported activities were restricted to seroprevalence studies
Njeru et al. BMC Public Health  (2016) 16:853 Page 12 of 15
of particular areas in Kenya. Similar to other African
countries, a great challenge for control programmes is the
lack of public and veterinary health services due to both
decreased governmental resources and the lack of interest
by the private sector to support it. For an effective control
strategy in Kenya, unregulated cross-border livestock
movements between neighboring countries along trade
routes, and nomadic movements in search of pasture and
watering points should be considered. These activities
may allow the entry and spread of infected herds present-
ing a challenge to the internal control activities, and re-
quire collaboration at the regional level.
Conclusion
The way forward and key lessons for Kenya
Our review has identified major gaps in the availability
of epidemiological data and diagnostic means. Brucel-
losis exposure is present in all animal production sys-
tems and wildlife. Human seroposivity is possibly linked
to direct and indirect contact with the livestock or con-
taminated animal products.
It is 100 years since the disease was first reported, but
little is known about the disease causing agents in
Kenya. Bacteriological and molecular typing data is
needed to highlight zoonotic potential, transmission dy-
namics, and to establish effective control measures.
Studies highlighted that patients with brucellosis are
likely misdiagnosed and possibly mistreated due to lack of
reliable laboratory diagnostic support and apparent ignor-
ance of physicians. A need for increased awareness of the
disease and efforts to establish reliable diagnostic capacity
in the hospitals is highly recommended. Based on available
evidence, it is likely that targeted vaccination of livestock
populations combined with sustained surveillance and
reporting systems, and public health education pro-
grammes focusing on the key socio-cultural and economic
risk factors identified, may be feasible control options for
the country. Eradication however seems unlikely.
The relevant authorities (veterinary health, wildlife
health and public health) should initiate well-designed
countrywide, evidence-based, and multidisciplinary stud-
ies of brucellosis at the human/livestock/wildlife inter-
face to generate reliable diseases incidence estimates,
potential impact, transmission dynamics, reservoirs and
effective targeted control strategies.
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